(OLMA) Olema Pharmaceuticals - Performance -57% in 12m
Compare OLMA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-71.16%
#101 in Group
Rel. Strength
13.22%
#6905 in Universe
Total Return 12m
-56.96%
#102 in Group
Total Return 5y
-90.47%
#110 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
32th Percentile in Group
12m Total Return: OLMA (-57%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: OLMA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for OLMA
Total Return (including Dividends) | OLMA | XBI | S&P 500 |
---|---|---|---|
1 Month | 52.61% | 11.81% | 13.81% |
3 Months | -9.50% | -13.61% | -6.30% |
12 Months | -56.96% | -12.29% | 10.65% |
5 Years | -90.47% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | OLMA | XBI | S&P 500 |
1 Month | 67.4% | 72.9% | 83% |
3 Months | -10.8% | -83% | -75.3% |
12 Months | -78.9% | -51.6% | 50.1% |
5 Years | -32.2% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #4 | 36.5% | 34.1% |
3 Month | #70 | 4.76% | -3.41% |
12 Month | #102 | -50.9% | -61.1% |
5 Years | #104 | -84.8% | -94.3% |
FAQs
Does OLMA Olema Pharmaceuticals outperforms the market?
No,
over the last 12 months OLMA made -56.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months OLMA made -9.50%, while XBI made -13.61%.
Over the last 3 months OLMA made -9.50%, while XBI made -13.61%.
Performance Comparison OLMA vs Indeces and Sectors
OLMA vs. Indices OLMA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -12.9% | 38.8% | -57.4% | -67.6% |
US NASDAQ 100 | QQQ | -13.1% | 35.3% | -57.6% | -68.6% |
US Dow Jones Industrial 30 | DIA | -13.3% | 42.6% | -57.1% | -64.7% |
German DAX 40 | DAX | -12.9% | 37.7% | -83.7% | -82.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | -15.1% | 40.8% | -58.2% | -64.3% |
Hongkong Hang Seng | HSI | -16.1% | 32.7% | -65.8% | -70.6% |
India NIFTY 50 | INDA | -7.98% | 47.8% | -57.8% | -56.8% |
Brasil Bovespa | EWZ | -14.0% | 35.4% | -66.1% | -48.6% |
OLMA vs. Sectors OLMA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -13.5% | 39.2% | -64.5% | -78.5% |
Consumer Discretionary | XLY | -13.3% | 38.4% | -56.4% | -71.2% |
Consumer Staples | XLP | -12.0% | 46.0% | -64.3% | -66.1% |
Energy | XLE | -12.7% | 45.9% | -50.8% | -47.5% |
Financial | XLF | -14.0% | 39.1% | -64.5% | -79.4% |
Health Care | XLV | -9.89% | 51.7% | -52.4% | -52.9% |
Industrial | XLI | -14.6% | 35.8% | -58.8% | -68.0% |
Materials | XLB | -12.7% | 39.1% | -52.5% | -51.7% |
Real Estate | XLRE | -11.6% | 41.1% | -58.2% | -72.4% |
Technology | XLK | -14.0% | 31.4% | -54.5% | -64.1% |
Utilities | XLU | -13.0% | 43.0% | -65.1% | -74.4% |
Aerospace & Defense | XAR | -14.9% | 31.5% | -68.9% | -84.3% |
Biotech | XBI | -6.31% | 40.8% | -37.3% | -44.7% |
Homebuilder | XHB | -13.4% | 41.1% | -44.2% | -49.4% |
Retail | XRT | -14.8% | 38.0% | -53.2% | -55.5% |